Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply

Annals of the Rheumatic Diseases

Volumn 73, Issue 4, 2014, Pages 763-770

  McHugh, Kirsty ^a   Rysnik, Oliwia ^a   Kollnberger, Simon ^a   Shaw, Jacqueline ^a   Utriainen, Lotta ^b   Al Mossawi, Mohammad Hussein ^a   Payeli, Sravan ^c   Marroquin, Osiris ^c   Milling, Simon ^b   Renner, Christoph ^c   Bowness, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HC10; MONOCLONAL ANTIBODY HD6; MONOCLONAL ANTIBODY ME 1; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL SUBPOPULATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SPLEEN CELL; SPONDYLARTHRITIS; STAINING; TRANSGENIC RAT;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; CELL LINE; COCULTURE TECHNIQUES; GENE DOSAGE; HLA-B27 ANTIGEN; HUMANS; HYDROGEN-ION CONCENTRATION; JURKAT CELLS; PEPTIDES; RATS; RATS, TRANSGENIC; RECEPTORS, KIR3DL2; SPLEEN; SPONDYLARTHRITIS;

EID: 84895465482     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-203080     Document Type: Article

References (29)

1. McHugh K, Bowness P. The link between HLA-B27 and SpA-new ideas on an old problem. Rheumatology (Oxford) 2012;51:1529-39.
2. May E, Dorris ML, Satumtira N, et al. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003;170:1099-105. (Pubitemid 36070566)
3. Taurog JD, Dorris ML, Satumtira N, et al. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009;60:1977-84.
4. Antoniou AN, Ford S, Taurog JD, et al. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem 2004;279:8895-902. (Pubitemid 38295950)
5. Dangoria NS, DeLay ML, Kingsbury DJ, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002;277:23459-68. (Pubitemid 34952180)
6. Mear JP, Schreiber KL, Munz C, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999;163:6665-70.
7. Bird LA, Peh CA, Kollnberger S, et al. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003;33:748-59. (Pubitemid 36367678)
8. Santos SG, Lynch S, Campbell EC, et al. Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cells. Arthritis Res Ther 2008;10:R100.
9. Allen RL, O'Callaghan CA, McMichael AJ, et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-8. (Pubitemid 29307101)
10. Kollnberger S, Bird L, Sun MY, et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002;46:2972-82. (Pubitemid 35315891)
11. Payeli SK, Kollnberger S, Osiris Marroquin B, et al. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondyloarthritis. Arthritis Rheum 2012;64:3139-49.
12. Utriainen L, Firmin D, Wright P, et al. Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis. Arthritis Rheum 2012;64:3199-209.
13. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112. (Pubitemid 120034950)
14. Taurog JD, Maika SD, Satumtira N, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999;169:209-23. (Pubitemid 29338734)
15. Ljunggren HG, Stam NJ, Ohlen C, et al. Empty MHC class I molecules come out in the cold. Nature 1990;346:476-80.
16. Baas EJ, van Santen HM, Kleijmeer MJ, et al. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J Exp Med 1992;176:147-56.
17. Townsend A, Ohlen C, Bastin J, et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:443-8. (Pubitemid 19191280)
18. Malik P, Klimovitsky P, Deng LW, et al. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J Immunol 2002;169:4379-87. (Pubitemid 35178212)
19. Zeh HJ III, Leder GH, Lotze MT, et al. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum Immunol 1994;39:79-86.
20. Tran TM, Satumtira N, Dorris ML, et al. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 2004;172:5110-9. (Pubitemid 38456440)
21. Kollnberger S, Bird LA, Roddis M, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004;173:1699-710. (Pubitemid 38971601)
22. Taurog JD, Maika SD, Simmons WA, et al. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168-78. (Pubitemid 23129798)
23. Aiko S, Grisham MB. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 1995;109:142-50.
24. Qian BF, Tonkonogy SL, Sartor RB. Aberrant innate immune responses in TLR-ligand activated HLA-B27 transgenic rat cells. Inflamm Bowel Dis 2008;14:1358-65.
25. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-37. (Pubitemid 350041542)
26. Steen KH, Steen AE, Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 1995;15(5 Pt 2):3982-9.
27. Fabian H, Loll B, Huser H, et al. Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. FEBS J 2011;278:1713-27.
28. Glatigny S, Fert I, Blaton MA, et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis rheum 2012;64:110-20.
29. Zhou M, Sayad A, Simmons WA, et al. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 1998;188:877-86. (Pubitemid 28433414)